Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

ASH 2019 | Myelomagenesis may start earlier than thought

Ola Landgren, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, outlines a study investigating the onset of multiple myeloma (MM). This analysis investigates the early stages of myelomagenesis, where the acquisition of the first key driver mutations precedes diagnosis by decades. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.